Come and join us across the globe
LINNC Paris 2026 LINNC China 2026 LINNC Seminar 2026 - Asia Edition LINNC Seminar 2026 - Americas Edition
 Founded by Pr. Jacques Moret 
Sign In
Come and join us across the globe
LINNC Paris 2026 LINNC China 2026 LINNC Seminar 2026 - Asia Edition LINNC Seminar 2026 - Americas Edition
 Founded by Pr. Jacques Moret 
Y-Stent-assisted coiling for Left MCA bifurcation aneurysm
The evolution and future of Surgical Robotics
Large paraclinoid aneurysm treated with flow diversion with OCT control
Jacques Moret, inside the mind of a pioneer
Cases
view more
“Slow-deconstructive” approach in a patient with acute stroke and fusiform MCA aneurysm
July 31, 2026
Elective thrombectomy with combined technique in M2 occlusion
May 19, 2026
Single-pass large-bore aspiration for acute left carotid T occlusion
April 2, 2026
ICA-M1 intracranial dissection EVT
February 19, 2026
A must-have guide for all the neurointerventionalists
20 years of INR trials in one unique synthetic format
Get your book now
INR Trials
LINNC TV
view more
Beyond the braid: Clinical evidence from a multi center early experience with the Surpass Elite® Flow Diverter
Why consider using a dedicated neck bridging device for wide neck bifurcation aneurysms?
Thrombectomy in 2036, what I learned from my trip to the future
Press releases
Galaxy Therapeutics Achieves CE Mark for SEAL™ Embolization System, Enabling Commercial Launch Across Europe and International Markets
August 19, 2026
Galaxy Therapeutics, a privately held medical device company dedicated to advancing the treatment of intracranial aneurysms, today announced that it has received CE Mark under the European Medical...
Acandis Receives Regulatory Approval to Launch SONIC Pivotal Clinical Investigation Evaluating the SILANCE® Stent for the Treatment of Idiopathic Intracranial Hypertension (IIH)
August 5, 2026
Acandis GmbH, a leading Germany medical technology company specialising in devices for neurovascular interventions, announced today that it has received approval from the German Federal Institute f...
Vesalio Appoints Greg Cook as Chief Commercial Officer
July 15, 2026
Greg Cook joins Vesalio as Chief Commercial Officer to lead commercial strategy and execution across its thrombectomy platform. Dallas, Texas – July 14, 2026
Newly Published Study Shows Sensome Clot-Sensing Guidewire Accurately Reveals True Clot Make-up in Fully Occluded Brain Vessels for First Time
May 4, 2026
In Situ Clot Intelligence Designed to Address Imaging Blind Spots During Mechanical Thrombectomy 
Congresses
view more
ESMINT congress
ESMINT congress
September 2, 2026 - September 4, 2026
European Society of Minimally Invasive Neurological Therapy
SVIN 26
SVIN Annual meeting
November 18, 2026 - November 20, 2026
Society of Vascular and Interventional Neurology 
18th Congress WFITN
18th Congress WFITN
October 11, 2026 - October 15, 2026
World Federation of Interventional and Therapeutic Neuroradiology
LINNC online is supported by an educational grant from
Balt Medtronic Stryker Terumo Neuro Vesalio Wallaby Phenox